Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc-binding motifs are specialized structural arrangements within proteins where a zinc ion (Zn2+) is coordinated by specific amino acid side chains, most commonly cysteine, histidine, aspartate, and glutamate [1]. These motifs are broadly categorized into catalytic sites, where the zinc ion directly participates in chemical catalysis, and structural sites, where the ion stabilizes the three-dimensional architecture of the protein, such as in zinc finger domains [2]. In catalytic motifs, the zinc ion often activates a water molecule for nucleophilic attack, a mechanism central to the function of enzymes like carbonic anhydrases and matrix metalloproteinases (MMPs) [3]. Structural zinc motifs are critical for DNA binding and protein-protein interactions, particularly in transcription factors [4]. While many individual zinc-containing proteins are validated therapeutic targets for cancer, glaucoma, and hypertension, the generic motif itself is not a single target but a structural feature shared by approximately 10% of the human proteome [5]. Pharmacological intervention typically involves small molecules with zinc-binding groups (ZBGs) that coordinate with the metal to inhibit enzyme activity, though achieving selectivity across different zinc-containing proteins remains a significant therapeutic challenge [6]. References: [1] McCall, K. A., et al. (2000). "Function and Mechanism of Zinc Metalloenzymes." Journal of Nutrition. [2] Auld, D. S. (2001). "Zinc coordination sphere in biochemical events." Biometals. [3] Maresca, A., et al. (2012). "Carbonic anhydrase inhibitors." Medical Research Reviews. [4] Klug, A. (2010). "The Discovery of Zinc Fingers and Their Applications in Gene Regulation and Genome Manipulation." Annual Review of Biochemistry. [5] Andreini, C., et al. (2006). "Counting the zinc-proteins encoded in the human genome." Journal of Proteome Research. [6] Puerta, D. T., et al. (2004). "Metalloenzyme inhibitors." Journal of the American Chemical Society.
Coordination of the zinc ion by zinc-binding groups (e.g., hydroxamates, sulfonamides, or carboxylates) to competitively inhibit catalytic activity or disrupt structural integrity [6].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Generic zinc-binding motifs in enzymes and structural proteins.